Topic - John Cardinal Farley

“Today’s approval addresses the great need for products to help reduce the impact of RSV disease on children, families and the health care system” said FDA's Dr. John Farley in a statement.

New drug to protect babies and toddlers from RSV gets FDA approval ahead of cold season →

Winds of change? Company looks at weather's effect on ball →